Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Neoadjuvant nivolumab was associated with few side effects, did not delay surgery, and induced a major pathological response in 45% of resected tumors. The tumor mutational burd...
Publications
2 shownTumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Most patients diagnosed with resected pancreatic adenocarcinoma (PDAC) survive less than 5 years, but a minor subset survives longer. Here, we dissect the role of the tumor micr...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,485
- Institution
- Bloomberg (United States)
External Links
Identifiers
- ORCID
- 0000-0002-7535-9179
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.